SQuID (subcutaneous insulin in diabetic ketoacidosis): Clinician acceptability.
Griffey RT, Schneider RM, Girardi M, LaRossa G, Yeary J, Frawley L, Ancona R, Kaser T, Suarez D, Cruz-Bravo P.
Griffey RT, et al. Among authors: schneider rm.
Acad Emerg Med. 2024 Sep 23. doi: 10.1111/acem.15019. Online ahead of print.
Acad Emerg Med. 2024.
PMID: 39313955